NCT00218153已完成3 期
Naltrexone Augmentation of Nicotine Patch Therapy
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 200
- 试验地点
- 2
研究概览
简要总结
Naltrexone Augmentation of Nicotine Patch Therapy
详细描述
This double blind placebo controlled study is designed to determine whether naltrexone can be used to help reduce cigarette use and craving for cigarettes. Eligible participants will receive 21mg transdermal nicotine as an outpatient. In addition, participants will receive one of three doses of naltrexone (25,50 or 100mg) or a placebo and brief counseling over the course of six weeks with follow-up appointments three, six, and twelve months after the beginning of treatment.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 99 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age 18 and older
- •Willingness and ability to give written consent
- •Smoking 20 cigarettes per day for at least 1 year
- •At least one prior attempt to stop smoking
- •Baseline expired carbon-monoxide level of at least 10 ppm
- •Weigh at least 100 lbs.
- •English speaking
- •One person per household
排除标准
- •Pregnant or nursing women or women who do not use a reliable form of birth control
- •Unstable cardiac disease
- •History of dermatoses
- •Current alcohol dependence
- •Current use of opiates
- •A urine drug screen that is positive for opiates
- •Serious current neurologic, psychiatric or medical illness
- •Chronic pain conditions necessitating opioid treatment
- •Evidence of significant hepatocellular injury as evidence by SGOT or SGPT >3 x normal or elevated bilirubin
- •Current use of smokeless tobacco, pipes, cigars, nicotine gum or nicotine patch
- •Patients requiring concomitant therapy with any psychotropic drug or on any drug with a psychotropic component
研究者
研究点 (2)
Loading locations...
相似试验
进行中（未招募）
不适用
The use of nicotine patches for the treatment of psoriasisPsoriasis - moderate to severeEUCTR2004-002058-69-GBniversity Hospitals of Leicester NHS Trust20
已完成
不适用
Motivation and Nicotine Patch Treatment for Under-served SmokersSmoking CessationNCT01684995The Miriam Hospital
终止
2 期
Study of Nicotine for Pain Associated With Chemotherapy-Induced Peripheral NeuropathyNeuropathyNeuropathic PainChemotherapy-induced Peripheral NeuropathyPeripheral NeuropathyNCT04468230Virginia Commonwealth University4
撤回
3 期
Study of Nicotine Replacement Therapy in PregnancySmoking CessationNCT00744913The Hospital for Sick Children
已完成
2 期
Selegiline Patch for Treatment of Nicotine DependenceTobacco Use DisorderNCT01330030Stanford University243